Foundayo vs Wegovy Pill: Routine, Results and Real Prices by Dose (2026)

We may earn a commission if you sign up or buy through links on this page. This doesn’t affect our rankings, which follow our methodology.

Foundayo vs Wegovy pill: both are FDA-approved, once-daily GLP-1 pills for weight management in adults, used alongside a reduced-calorie diet and more physical activity. The Wegovy pill needs an empty stomach, up to 4 oz of water and a 30-minute wait; Foundayo can be taken any time, with or without food. In separate trials, average weight loss was 13.6% and 11.1%, and both top doses cost $299 a month self-pay.

Below, we compare the FDA labels of these two oral GLP-1 medicines, their trials and the prices on each manufacturer’s pharmacy (checked November 14, 2026), including a first year’s cost.

Foundayo vs Wegovy pill: how your morning changes

The Wegovy pill has to be the first thing you swallow each morning, alone, with a little water. Foundayo has no food or water rules: you take it once a day whenever suits you.

Label rule	Wegovy pill (oral semaglutide)	Foundayo (orforglipron)
When	Once daily, in the morning	Once daily, any time
Food	Empty stomach	With or without food
Liquid	Water only, up to 4 oz	No restriction
Wait before eating, drinking or other oral meds	At least 30 minutes	None
Tablet	Swallow whole; do not split, crush, chew or dissolve	Swallow whole; do not break, crush or chew
Missed dose	Skip it, take the next one the following day	Take it as soon as you remember; never take two in one day. After 7 or more missed days in a row, the label says to restart at a lower dose: ask your prescriber

Sources: Wegovy prescribing information §2.1 and §2.4; Foundayo prescribing information §2.1 and §2.3.

Why the difference? Semaglutide is a peptide, and in tablet form only about 1% to 2% of it is absorbed, according to the Wegovy label. Drinking more water or eating too soon after the tablet lowers that further, according to the label’s absorption studies. Orforglipron is a small molecule, not a peptide, and the Foundayo label reports no clinically relevant food effect.

The 30-minute wait matters most if you already take other morning pills, such as thyroid medicine: ask your pharmacist how to fit them together. The Wegovy label also reports that the semaglutide tablet raised levothyroxine (thyroid hormone) levels by about a third (33%) in a study, so thyroid levels may need monitoring. Both pills slow stomach emptying and can change how other oral medicines are absorbed.

Which GLP-1 pill led to more weight loss in trials?

In its main trial, the Wegovy pill 25 mg produced a larger average weight loss (13.6%) than Foundayo’s highest dose did in its own trial (11.1%). These were separate trials with different designs, so that gap is not a reliable head-to-head result.

Trial	Who took part	Length	Dose	Average weight change vs placebo	Lost 15% or more
OASIS 4, Wegovy pill	307 adults without diabetes	64 weeks	25 mg	−13.6% vs −2.4%	47% vs 5.5%
ATTAIN-1, Foundayo	3,127 adults without diabetes	72 weeks	17.2 mg (9 mg: −8.3%; 5.5 mg: −7.4%)	−11.1% vs −2.1%	35.9% vs 6%
ATTAIN-2, Foundayo	1,613 adults with type 2 diabetes	72 weeks	17.2 mg	−9.6% vs −2.5%	25.9% vs 3.1%

Figures are from the FDA labels and count everyone randomized, including people who stopped treatment. For OASIS 4, the OASIS 4 paper in NEJM reports −2.2% on placebo from a slightly different analysis; the Wegovy label shows −2.4%. Results vary widely from person to person: some people lose much more than the average, others little or none. To translate a percentage into pounds for your own weight, see what trial results could mean in pounds.

Why you can’t line these numbers up directly

• Size: OASIS 4 randomized 307 people; ATTAIN-1 enrolled 3,127, about ten times more.
• Length: 64 weeks versus 72 weeks.
• Who enrolled: OASIS 4 was 79% women and 92% White. ATTAIN-1 was 64% women and 28% Asian.
• No direct comparison: the one trial that pitted the two molecules against each other, ACHIEVE-3, enrolled adults with type 2 diabetes and, in an open-label, 52-week trial, compared orforglipron with lower oral semaglutide doses (7 mg and 14 mg, the Rybelsus range), not the Wegovy pill 25 mg. We found no published trial comparing orforglipron with oral semaglutide at weight-loss doses (as of November 14, 2026).

You may also see “about 17%” in Novo Nordisk’s own announcement. That 16.6% figure is what the trial estimated if all patients had stayed on treatment, not the result for everyone randomized.

What the evidence says: grade A for each pill versus placebo (randomized, placebo-controlled trials, though OASIS 4 was small, with 307 people). Grade D for “which one works better,” because no trial has compared them directly at weight-loss doses.

What does each pill cost without insurance?

As of November 14, 2026, Foundayo costs $149 to $299 per month at LillyDirect without insurance, and the Wegovy pill costs the same range at NovoCare. Foundayo’s 2nd and 3rd strengths cost less until December 31, 2026, and the two cost the same $299 at the top.

Label strength order	Wegovy pill at NovoCare	Foundayo at LillyDirect
1st strength	1.5 mg: $149	0.8 mg: $149
2nd strength	4 mg: $199	2.5 mg: $149*
3rd strength	9 mg: $299	5.5 mg: $199*
Higher strengths	25 mg: $299	9 mg: $299 · 14.5 mg: $299† · 17.2 mg: $299†
What counts as a “month”	1 bottle of 30 tablets	30 days
Self-pay page (prescription required)	See pricing	See pricing

* Lilly says the 2.5 mg and 5.5 mg prices are “temporarily reduced through December 31, 2026.” The regular price is not shown. † Only “when you refill within 45 days” under Lilly’s self-pay refill program; otherwise regular prices apply (amount not shown).

All prices are self-pay only, need a prescription, may add taxes or fees, and can change.

First-year cost: example prices

To compare the Foundayo vs Wegovy pill bill over a year, we added up 12 monthly fills at the prices above, following the label’s dose schedule at its shortest intervals (30 days per step), and assuming November 2026 prices hold all year, except where the manufacturer has announced an end date. These are price examples, not a dosing plan. Your dose and when it changes depend on how you respond and what side effects you have, and your prescriber decides them. Don’t choose or hold a dose because of its price; if cost is a problem, tell your prescriber.

Example dose path (for pricing only)	12-month medication cost
Wegovy pill, reaching 25 mg in month 4	$3,338
Foundayo, reaching 17.2 mg in month 6, refilling within 45 days	$3,188 or more*
Year 2 at $299 a month, either pill	$3,588

*If you start in November 2026, month 3 falls in January 2027, after Lilly’s reduced 5.5 mg price ends on December 31, 2026. Lilly does not show the regular price, so this total is a minimum. For the same reason, we can’t price a year spent mostly at 5.5 mg: the $199 price only runs through December 31, 2026. Telehealth membership fees come on top (next section). To run your own numbers, estimate your own yearly cost.

With commercial insurance that covers the drug, both companies advertise savings cards from $25 a month (NovoCare caps savings at $100 a month); people with government insurance are excluded.

Where can you get Foundayo or the Wegovy pill?

You can fill either pill at its manufacturer’s pharmacy with a prescription, or go through a telehealth program that prescribes it. Programs usually charge a membership on top of the medication.

Where	Foundayo	Wegovy pill	Fee on top of medication
LillyDirect	$149-$299	No	None (pharmacy; prescription needed)
NovoCare Pharmacy	No	$149-$299	None (pharmacy; prescription needed)
Hims & Hers	“Starts at $149” (Lilly release)	Not checked	Not published
Mochi Health	“As low as $149”	“As low as $149”	$49-$79 a month
WW Clinic (Med+)	From $149	From $149	$74 a month, 12-month plan
Sesame	$149-$349 by dose, as listed by Sesame	From $149	Care subscription extra
Ivim Health	No	$149 / $199 / $299	$75 a month

Telehealth figures were read on each program’s site on November 13, 2026, except Hims & Hers (from Lilly’s November 6, 2026 release, as the Hims site blocked our check). For every fee and cancellation term, see our weight-loss program price tracker.

If you have Medicare Part D, both manufacturers point eligible patients to the Medicare GLP-1 Bridge, where covered GLP-1s cost $50 a month. We cover eligibility in an upcoming guide to the Bridge.

Side effects: is one GLP-1 pill harder to tolerate?

Both pills mainly cause stomach and gut side effects, most often during dose increases. There is no head-to-head data at weight-loss doses. In ACHIEVE-3, the only direct comparison (adults with type 2 diabetes, lower oral semaglutide doses), more people had digestive side effects on orforglipron (58% to 59%) than on oral semaglutide (37% to 45%), and more quit over side effects (9% to 10% versus 4% to 5%).

Foundayo (pooled ATTAIN trials, label Table 1):

• Nausea: 26%, 34% and 35% at 5.5, 9 and 17.2 mg, versus 10% on placebo.
• Vomiting: 13% to 24%, versus 4%.
• Any digestive side effect: 60% to 69%, versus 37%.
• Stopped because of side effects: 8% overall (10% at 17.2 mg), versus 3%.

Wegovy pill (OASIS 4):

• Any digestive side effect: 74.0%, versus 42.2% on placebo.
• Stopped treatment because of side effects: 6.9%, versus 5.9%.

Both labels warn about serious risks: pancreatitis, gallbladder disease, severe stomach side effects (neither is recommended with severe gastroparesis), kidney injury from dehydration after vomiting or diarrhea, serious allergic reactions, low blood sugar when combined with insulin or sulfonylureas, and food entering the lungs during anesthesia or deep sedation. The Wegovy label also asks for regular heart-rate checks. Tell your surgical team you take a GLP-1.

NAION (a rare eye condition that can cause sudden vision loss in one eye): on November 9, 2026, the FDA announced in a drug safety communication that it is requiring all GLP-1 receptor agonist medicines, including Wegovy and Foundayo, to add a warning about this potential risk to their labels. In an FDA analysis of 126 trials, NAION occurred at 6.4 cases per 100,000 person-years with GLP-1s versus 3.8 with placebo or other diabetes medicines, based on very few cases overall.

The labels we read (June and July 2026) predate this change. If you notice sudden vision loss, blurry vision, a blind spot, or dim or missing areas of vision in one eye, contact a healthcare professional right away. If NAION is confirmed, your prescriber will discuss whether to continue. We are preparing a dedicated explainer.

Beyond weight: the label differences that may decide it

Two differences stand out: only Wegovy tablets are approved to lower heart risk, and Foundayo comes with more drug-interaction rules. Your prescriber will check both against your history.

Wegovy tablets:

• Also approved to reduce the risk of heart attack, stroke and cardiovascular death in adults with established heart disease and obesity or overweight.
• The label says to stop it at least 2 months before a planned pregnancy, because semaglutide stays in the body for a long time. Plan this with your prescriber.

Foundayo:

• Strong CYP3A4 inhibitors (CYP3A4 is a liver enzyme that clears many drugs; the label’s examples include the antibiotic clarithromycin and the HIV medicine ritonavir) limit which Foundayo doses can be used, and some combinations should be avoided.
• Strong CYP3A4 inducers, such as the seizure medicine carbamazepine, should be avoided because they can make Foundayo less effective.
• Simvastatin, a cholesterol drug, is limited to 20 mg a day.
• Not recommended with severe liver impairment.
• Thyroid boxed warning: orforglipron doesn’t act on the GLP-1 receptor of rats or mice, so the animal tests that flagged thyroid tumors with other GLP-1 drugs can’t tell us whether it carries the same risk. Foundayo has the same boxed warning and the same contraindications as the Wegovy pill.

Both are approved only for adults with obesity, or with overweight plus at least one weight-related health condition: check whether you meet the label’s BMI criteria. Then ask your doctor which pill fits your health history.

Pill or shot: is the Wegovy injection or Zepbound a better comparison?

For some people, the Wegovy pill vs Foundayo question is really a choice between a pill and a weekly shot. Self-pay, the Wegovy injection costs $349 a month at NovoCare for doses up to 2.4 mg ($399 for the 7.2 mg HD pen), after a $199 introductory offer on the first two fills for new patients that runs through December 31, 2026. Zepbound vials or pens cost $299 to $449 a month at LillyDirect, with the higher doses tied to refilling within 45 days.

The Wegovy label allows switching between the 2.4 mg injection and the 25 mg tablets; your prescriber decides whether and how.

Foundayo vs Wegovy pill: key takeaways

• Foundayo fits a flexible routine; the Wegovy pill needs a strict morning ritual.
• The Wegovy pill showed more weight loss in its own trial; no direct comparison exists.
• Wegovy pill cost and Foundayo cost both top out at $299 per month without insurance; Foundayo’s cheaper middle strengths are temporary.
• Only Wegovy tablets have a heart-risk indication.
• Both pills can change how other oral medicines are absorbed; Foundayo adds specific checks (CYP3A4 drugs, simvastatin, oral birth control).

Frequently asked questions

Can Foundayo be split in half?

No. The Foundayo label says to swallow the tablet whole and not to break, crush or chew it. The Wegovy tablet label has the same rule: do not split, crush, chew or dissolve it. If swallowing pills is hard for you, mention it to your prescriber before starting.

Does Foundayo cause hair loss?

Hair loss is a listed side effect. In the pooled ATTAIN trials, 4% to 5% of people on Foundayo reported it, versus 2% on placebo, and it was linked to weight reduction. Women reported it more often than men (7% versus 0.9%). Tell your clinician if you notice it.

Does Foundayo affect birth control?

Yes, for birth control pills. The Foundayo label advises a non-oral method, or adding a barrier method, for 30 days after starting and after each dose increase; non-oral hormonal methods should not be affected. The Wegovy label has no equivalent instruction, and its interaction studies found no meaningful change in birth control pill hormones.

Is there a Foundayo coupon?

There is no separate coupon. If your commercial insurance covers Foundayo, Lilly’s savings card can bring the cost to as low as $25 a month; people with government insurance are excluded. Without coverage, the Foundayo cost is the LillyDirect self-pay price in our table.

Does Foundayo lower A1C?

Foundayo is FDA-approved for weight management only, not for type 2 diabetes, as of November 14, 2026. Trials in people with type 2 diabetes, including ATTAIN-2 and ACHIEVE-3, reported lower A1C, but that use is not on the label. Discuss diabetes treatment with your clinician.

Conclusion

In the Foundayo vs Wegovy pill choice, Foundayo suits people who want no food or water rules, or who already juggle several morning medicines (after a pharmacist checks them for interactions). The Wegovy pill suits people who can keep a strict morning routine and may benefit from its heart-risk indication. At the top dose, the price is the same. Talk to your doctor before choosing either.

What to read next

• Compare what each telehealth program charges on top of the pill
• Run your own numbers for 6 or 12 months
• Check if you meet the FDA label criteria

This article is for information only and does not replace advice from your healthcare provider. Talk to your doctor or pharmacist before starting, stopping or changing any medication. How we work: every claim is checked against the current FDA labels and published trials, and we state the level of evidence for each option. Prices and labels change; we last checked them on November 14, 2026.